Ternary solid dispersions: classification and formulation considerations

References

• Al-Kassas R, Bansal M, Shaw J. Nanosizing techniques for improving bioavailability of drugs. J Control Release. 2017;260:202–212.
   PubMed Web of Science ®Google Scholar
• Johnson JLH, He Y, Yalkowsky SH. Prediction of precipitation-induced phlebitis: a statistical validation of an in vitro model. J Pharm Sci. 2003;92(8):1574–1581.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85(10):1017–1025.
   PubMed Web of Science ®Google Scholar
• Matloob AH, Mourtas S, Klepetsanis P, et al. Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study. Int J Pharm. 2014;476(1-2):108–115.
   PubMedGoogle Scholar
• Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm. 2002;244(1-2):127–135.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12(23-24):1068–1075.
   PubMed Web of Science ®Google Scholar
• Tran P, Pyo Y-C, Kim D-H, et al. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 2019;11(3):132.
   PubMed Web of Science ®Google Scholar
• Gala UH, Miller DA, Williams RO. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188319.
   PubMed Web of Science ®Google Scholar
• Kumar V, Mintoo MJ, Mondhe DM, et al. Binary and ternary solid dispersions of an anticancer preclinical lead, IIIM-290: In vitro and in vivo studies. Int J Pharm. 2019;570:118683.
   PubMedGoogle Scholar
• Davis MT, Potter CB, Mohammadpour M, et al. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions. Int J Pharm. 2017;519(1-2):365–372.
   PubMedGoogle Scholar
• Tian B, Ju X, Yang D, et al. Effect of the third component on the aging and crystallization of cinnarizine-soluplus® binary solid dispersion. Int J Pharm. 2020;580:119240.
   PubMedGoogle Scholar
• Ueda K, Yamazoe C, Yasuda Y, et al. Mechanism of enhanced nifedipine dissolution by polymer-blended solid dispersion through molecular-level characterization. Mol Pharm. 2018;15(9):4099–4109.
   PubMedGoogle Scholar
• Guan J, Jin L, Liu Q, et al. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption. Eur J Pharm Sci. 2019;139:105043.
   PubMed Web of Science ®Google Scholar
• Prasad D, Chauhan H, Atef E. Role of molecular interactions for synergistic precipitation inhibition of poorly soluble drug in supersaturated drug-polymer-polymer ternary solution. Mol Pharm. 2016;13(3):756–765.
   PubMedGoogle Scholar
• Shi X, Xu T, Huang W, et al. Stability and bioavailability enhancement of telmisartan ternary solid dispersions: the synergistic effect of polymers and drug-polymer(s) interactions. AAPS PharmSciTech. 2019;20(4):143.
   PubMed Web of Science ®Google Scholar
• Schittny A, Huwyler J, Puchkov M. Mechanisms of increased bioavailability through amorphous solid dispersions: a review. Drug Deliv. 2020;27(1):110–127.
   PubMed Web of Science ®Google Scholar
• Solanki NG, Gumaste SG, Shah AV, et al. Effects of surfactants on itraconazole-hydroxypropyl methylcellulose acetate succinate solid dispersion prepared by hot melt extrusion. II: rheological analysis and extrudability testing. J Pharm Sci. 2019;108(9):3063–3073.
   PubMed Web of Science ®Google Scholar
• Solanki NG, Lam K, Tahsin M, et al. Effects of surfactants on itraconazole-HPMCAS Solid dispersion prepared by hot-melt extrusion I: miscibility and drug release. J Pharm Sci. 2019;108(4):1453–1465.
   PubMed Web of Science ®Google Scholar
• Qi S, Roser S, Edler KJ, et al. Insights into the role of polymer-surfactant complexes in drug solubilisation/stabilisation during drug release from solid dispersions. Pharm Res. 2013;30(1):290–302.
   PubMed Web of Science ®Google Scholar
• Nilsson S. Interactions between water-soluble cellulose derivatives and surfactants. 1. The HPMC/SDS/water system. Macromolecules. 1995;28(23):7837–7844.
   Web of Science ®Google Scholar
• Rashid R, Kim DW, Ud Din F, et al. Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym. 2015;130:26–31.
   PubMed Web of Science ®Google Scholar
• Baghel S, Cathcart H, O'Reilly NJ. Investigation into the solid-state properties and dissolution profile of spray-dried ternary amorphous solid dispersions: a rational step toward the design and development of a multicomponent amorphous system. Mol Pharm. 2018;15(9):3796–3812.
   PubMedGoogle Scholar
• Feng D, Peng T, Huang Z, et al. Polymer–surfactant system based amorphous solid dispersion: precipitation inhibition and bioavailability enhancement of itraconazole. Pharmaceutics. 2018;10(2):53.
   Web of Science ®Google Scholar
• Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int J Pharm. 2007;328(2):119–129.
   PubMed Web of Science ®Google Scholar
• Chamsai B, Limmatvapirat S, Sungthongjeen S, et al. Enhancement of solubility and oral bioavailability of manidipine by formation of ternary solid dispersion with d-α-tocopherol polyethylene glycol 1000 succinate and copovidone. Drug Dev Ind Pharm. 2017;43(12):2064–2075.
   PubMed Web of Science ®Google Scholar
• Kakran M, Sahoo NG, Tan YW, et al. Ternary dispersions to enhance solubility of poorly water soluble antioxidants. Colloids Surf. Physicochem. Eng. Asp. 2013;433:111–121.
   Web of Science ®Google Scholar
• Yan Y-D, Sung JH, Kim KK, et al. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm. 2012;422(1-2):202–210.
   PubMedGoogle Scholar
• Sawicki E, Beijnen JH, Schellens JHM, et al. Pharmaceutical development of an oral tablet formulation containing a spray dried amorphous solid dispersion of docetaxel or paclitaxel. Int. J. Pharm. 2016;511(2):765–773.
   PubMedGoogle Scholar
• Nanaki S, Eleftheriou RM, Barmpalexis P, et al. Evaluation of dissolution enhancement of aprepitant drug in ternary pharmaceutical solid dispersions with Soluplus® and poloxamer 188 prepared by melt mixing. Sci. 2019;1(1):11.
   Google Scholar
• Kim YH, Kim DW, Kwon MS, et al. Clopidogrel napadisilate monohydrate loaded surface-modified solid dispersion: physicochemical characterization and in vivo evaluation. Biol Pharm Bull. 2015;38(7):1033–1040.
   PubMed Web of Science ®Google Scholar
• Koh PT, Chuah JN, Talekar M, et al. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems. Indian J Pharm Sci. 2013;75(3):291–301.
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Kang W-S, Piao J, et al. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Drug Des. Devel. Ther. 2015;9:2745–2756.
   PubMed Web of Science ®Google Scholar
• Ha E-S, Kim J-S, Baek I, et al. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process. Drug Des Devel Ther. 2015;9:4269–4277.
   PubMed Web of Science ®Google Scholar
• Cho Y, Ha E-S, Baek I-H, et al. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® E. Molecules. 2015;20(6):9496–9509.
   PubMed Web of Science ®Google Scholar
• Wang X, Michoel A, Van den Mooter G. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm. 2005;303(1-2):54–61.
   PubMedGoogle Scholar
• Maghraby GME, Alomrani AH. Synergistic enhancement of itraconazole dissolution by ternary system formation with pluronic F68 and hydroxypropylmethylcellulose. Sci. Pharm. 2009;77:401–418.
   Google Scholar
• Janssens S, Nagels S, de Armas HN, et al. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm. 2008;69(1):158–166.
   PubMed Web of Science ®Google Scholar
• Szuts A, Láng P, Ambrus R, et al. Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology. Int J Pharm. 2011;410(1-2):107–110.
   PubMedGoogle Scholar
• Moes J, Koolen S, Huitema A, et al. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel. Eur J Pharm Biopharm. 2013;83(1):87–94.
   PubMed Web of Science ®Google Scholar
• Janssens S, Humbeeck JV, den Mooter GV. Evaluation of the formulation of solid dispersions by co-spray drying itraconazole with Inutec SP1, a polymeric surfactant, in combination with PVPVA 64. Eur J Pharm Biopharm. 2008;70(2):500–505.
   PubMed Web of Science ®Google Scholar
• Mosquera-Giraldo LI, Trasi NS, Taylor LS. Impact of surfactants on the crystal growth of amorphous celecoxib. Int J Pharm. 2014;461(1-2):251–257.
   PubMedGoogle Scholar
• Zi P, Zhang C, Ju C, et al. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. Eur J Pharm Sci. 2019;134:233–245.
   PubMed Web of Science ®Google Scholar
• Bajracharya R, Lee SH, Song JG, et al. Development of a ternary solid dispersion formulation of LW6 to improve the in vivo activity as a BCRP inhibitor: preparation and in vitro/in vivo characterization. Pharmaceutics. 2019;11(5):206.
   Web of Science ®Google Scholar
• Yin X, Daintree LS, Ding S, et al. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Drug Des Devel Ther. 2015;9:2801–2810.,
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Willems T, Van den Mooter G. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. Eur J Pharm Sci. 2008;34(4-5):293–302.
   PubMed Web of Science ®Google Scholar
• Nair R, Nyamweya N, Gönen S, et al. Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int J Pharm. 2001;225(1-2):83–96.
   PubMed Web of Science ®Google Scholar
• Al-Obaidi H, Ke P, Brocchini S, et al. Characterization and stability of ternary solid dispersions with PVP and PHPMA. Int J Pharm. 2011;419(1-2):20–27.
   PubMedGoogle Scholar
• Kuo S-W, Shih C-C, Shieh J-S, et al. Specific interactions in miscible polymer blends of poly(2-hydroxypropyl methacrylate) with polyvinylpyrrolidone. Polym Int. 2004;53(2):218–224.
   Web of Science ®Google Scholar
• Prasad D, Chauhan H, Atef E. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects. J Pharm Sci. 2014;103(11):3511–3523.
   PubMed Web of Science ®Google Scholar
• Meeus J, Scurr DJ, Chen X, et al. Combination of (M)DSC and surface analysis to study the phase behaviour and drug distribution of ternary solid dispersions. Pharm Res. 2015;32(4):1407–1416.
   PubMed Web of Science ®Google Scholar
• Albadarin AB, Potter CB, Davis MT, et al. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus® processed by hot melt extrusion. Int J Pharm. 2017;532(1):603–611.
   PubMedGoogle Scholar
• Davis MT, Potter CB, Walker GM. Downstream processing of a ternary amorphous solid dispersion: The impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution. Int J Pharm. 2018;544(1):242–253.
   PubMed Web of Science ®Google Scholar
• Shuai S, Yue S, Huang Q, et al. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Eur J Drug Metab Pharmacokinet. 2016;41(4):413–422.
   PubMed Web of Science ®Google Scholar
• Hirasawa N, Ishise S, Miyata H, et al. An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems. Drug Dev Ind Pharm. 2003;29(9):997–1004.
   PubMed Web of Science ®Google Scholar
• Park GB, Yoon H, Bae JW, et al. Release behavior of cilostazol according to the fabrication methods and ratio of HPMC/PVP. Macromol Res. 2013;21(9):971–976.
   Web of Science ®Google Scholar
• Taupitz T, Dressman JB, Klein S. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm. 2013;84(1):208–218.
   PubMed Web of Science ®Google Scholar
• Lim SM, Pang ZW, Tan HY, et al. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems. Drug Dev Ind Pharm. 2015;41(11):1847–1855.
   PubMed Web of Science ®Google Scholar
• Beig A, Fine-Shamir N, Lindley D, et al. Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability. Aaps J. 2017;19(3):806–813.
   PubMed Web of Science ®Google Scholar
• Gala U, Miller D, Williams RO. Improved dissolution and pharmacokinetics of abiraterone through KinetiSol® enabled amorphous solid dispersions. Pharmaceutics. 2020;12(4):357.
   Web of Science ®Google Scholar
• Zoeller T, Dressman JB, Klein S. Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions. Int J Pharm. 2012;430(1-2):176–183.
   PubMedGoogle Scholar
• Alhijjaj M, Bouman J, Wellner N, et al. Creating drug solubilization compartments via phase separation in multicomponent buccal patches prepared by direct hot melt extrusion-injection molding. Mol Pharm. 2015;12(12):4349–4362.
   PubMedGoogle Scholar
• Cirri M, Mura P, Rabasco AM, et al. Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev. Ind. Pharm. 2004;30(1):65–74.
   PubMed Web of Science ®Google Scholar
• Al-Obaidi H, Buckton G. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS. AAPS PharmSciTech. 2009;10(4):1172–1177.
   PubMed Web of Science ®Google Scholar
• Janssens S, Roberts C, Smith EF, et al. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends. Int J Pharm. 2008;355(1-2):100–107.
   PubMedGoogle Scholar
• Kalivoda A, Fischbach M, Kleinebudde P. Application of mixtures of polymeric carriers for dissolution enhancement of oxeglitazar using hot-melt extrusion. Int J Pharm. 2012;439(1-2):145–156.
   PubMedGoogle Scholar
• Higashi K, Seo A, Egami K, et al. Mechanistic insight into the dramatic improvement of probucol dissolution in neutral solutions by solid dispersion in Eudragit E PO with saccharin. J Pharm Pharmacol. 2016;68(5):655–664.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1-2):1–11.
   PubMed Web of Science ®Google Scholar
• Singh SK, Srinivasan KK, Singare DS, et al. Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds. Drug Dev Ind Pharm. 2012;38(11):1328–1336.
   PubMed Web of Science ®Google Scholar
• Dong L, Mai Y, Liu Q, et al. Mechanism and improved dissolution of glycyrrhetinic acid solid dispersion by alkalizers. Pharmaceutics. 2020;12(1):82.
   PubMed Web of Science ®Google Scholar
• Martins RM, Machado MO, Pereira SV, et al. Microparticulated hydrochlorothiazide solid dispersion: enhancing dissolution properties via spray drying. Dry. Technol. 2012;30(9):959–967.
   Web of Science ®Google Scholar
• Hanada M, Jermain SV, Williams RO. Enhanced dissolution of a porous carrier-containing ternary amorphous solid dispersion system prepared by a hot melt method. J Pharm Sci. 2018;107(1):362–371.
   PubMed Web of Science ®Google Scholar
• Luo D, Kim JH, Park C, et al. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium. Int J Pharm. 2017;523(1):343–356.
   PubMedGoogle Scholar
• Papadimitriou S, Bikiaris D. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers. Drug Dev Ind Pharm. 2009;35(9):1128–1138.
   PubMed Web of Science ®Google Scholar
• Park CW, Tung NT, Rhee YS, et al. Physicochemical, pharmacokinetic and pharmacodynamic evaluations of novel ternary solid dispersion of rebamipide with poloxamer 407. Drug Dev Ind Pharm. 2013;39(6):836–844.
   PubMed Web of Science ®Google Scholar
• Patel JR, Carlton RA, Yuniatine F, et al. Preparation and structural characterization of amorphous spray-dried dispersions of tenoxicam with enhanced dissolution. J Pharm Sci. 2012;101(2):641–663.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ren W, Dushkin AV, et al. Preparation, characterization, in vitro and in vivo studies of olmesartan medoxomil in a ternary solid dispersion with N-methyl-D-glucamine and hydroxypropyl-β-cyclodextrin. J Drug Deliv Sci Technol. 2020;56:101546.
   Web of Science ®Google Scholar
• Paidi SK, Jena SK, Ahuja BK, et al. Preparation, in-vitro and in-vivo evaluation of spray-dried ternary solid dispersion of biopharmaceutics classification system class II model drug. J Pharm Pharmacol. 2015;67(5):616–629.
   PubMed Web of Science ®Google Scholar
• Nakahashi T, Matsumoto T, Wakiyama N, et al. The role of light anhydrous silicic acid on physical stability of troglitazone solid dispersion under humidified conditions. Adv Powder Technol. 2014;25(2):716–721.
   Google Scholar
• Hülsmann S, Backensfeld T, Keitel S, et al. Melt extrusion–an alternative method for enhancing the dissolution rate of 17beta-estradiol hemihydrate. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2000;49(3):237–242.
   PubMed Web of Science ®Google Scholar
• Ghanavati R, Taheri A, Homayouni A. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier. Mater Sci Eng C Mater Biol Appl. 2017;72:501–511.
   PubMed Web of Science ®Google Scholar
• Pradhan R, Tran TH, Choi JY, et al. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability. Arch Pharm Res. 2015;38(4):522–533.
   PubMed Web of Science ®Google Scholar
• Nguyen DN, Van den Mooter G. The fate of ritonavir in the presence of darunavir. Int J Pharm. 2014;475(1-2):214–226.
   PubMedGoogle Scholar
• Löbmann K, Laitinen R, Grohganz H, et al. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. Mol Pharm. 2011;8(5):1919–1928.
   PubMed Web of Science ®Google Scholar
• Dengale SJ, Ranjan OP, Hussen SS, et al. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions. Eur J Pharm Sci. 2014;62:57–64.
   PubMed Web of Science ®Google Scholar
• Löbmann K, Strachan C, Grohganz H, et al. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. Eur J Pharm Biopharm. 2012;81(1):159–169.
   PubMed Web of Science ®Google Scholar
• Riekes MK, Engelen A, Appeltans B, et al. New perspectives for fixed dose combinations of poorly water-soluble compounds: a case study with ezetimibe and lovastatin. Pharm Res. 2016;33(5):1259–1275.
   PubMed Web of Science ®Google Scholar
• Trasi NS, Taylor LS. Dissolution performance of binary amorphous drug combinations-Impact of a second drug on the maximum achievable supersaturation. Int J Pharm. 2015;496(2):282–290.
   PubMedGoogle Scholar
• Pacult J, Rams-Baron M, Chmiel K, et al. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions. Eur J Pharm Sci. 2019;136:104947.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Bogner RH, Goldman D, et al. Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage. Pharm Dev Technol. 2002;7(1):103–112.
   PubMed Web of Science ®Google Scholar
• Araújo RR, Teixeira CCC, Freitas LAP. The Preparation of Ternary Solid Dispersions of an Herbal Drug via Spray Drying of Liquid Feed. Dry. Technol. 2010;28(3):412–421.
   Web of Science ®Google Scholar
• Kim S-J, Lee H-K, Na Y-G, et al. A novel composition of ticagrelor by solid dispersion technique for increasing solubility and intestinal permeability. Int J Pharm. 2019;555:11–18.
   PubMed Web of Science ®Google Scholar
• Martins RM, Siqueira S, Tacon LA, et al. Microstructured ternary solid dispersions to improve carbamazepine solubility. Powder Technol. 2012;215-216:156–165.
   Web of Science ®Google Scholar
• Teixeira CCC, Mendonça LM, Bergamaschi MM, et al. Microparticles containing curcumin solid dispersion: stability, bioavailability and anti-inflammatory activity. AAPS PharmSciTech. 2016;17(2):252–261.
   PubMed Web of Science ®Google Scholar
• Baghel S, Cathcart H, O'Reilly NJ. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium. Eur J Pharm Biopharm. 2016;107:16–31.
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88(10):1058–1066.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Marques S, das Neves J, et al. Amorphous solid dispersions: Rational selection of a manufacturing process. Adv Drug Deliv Rev. 2016;100:85–101.
   PubMed Web of Science ®Google Scholar
• Lin Y, Cogdill RP, Wildfong PLD. Informatic calibration of a materials properties database for predictive assessment of mechanically activated disordering potential for small molecule organic solids. J Pharm Sci. 2009;98(8):2696–2708.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971;60(9):1281–1302.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV. 2000;50(1):47–60.
   PubMed Web of Science ®Google Scholar
• Sahoo NG, Kakran M, Li L, et al. Dissolution enhancement of a poorly water-soluble antimalarial drug by means of a modified multi-fluid nozzle pilot spray drier. Mater. Sci. Eng. C. 2011;31(2):391–399.
   Web of Science ®Google Scholar
• T. c/o S.C.R.C. Hoshino, F. c/o S.C.R.C. Kusaki, I. c/o S.C.R.C. Fukui, Solid dispersion preparation, EP1847260A2, 2007. https://patents.google.com/patent/EP1847260A2/nl. (accessed April 4, 2020).
   Google Scholar
• Xie T, Taylor LS. Effect of temperature and moisture on the physical stability of binary and ternary amorphous solid dispersions of celecoxib. J Pharm Sci. 2017;106(1):100–110.
   PubMed Web of Science ®Google Scholar
• Vo CL-N, Park C, Lee B-J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 2013;85(3 Pt B):799–813.
   PubMed Web of Science ®Google Scholar
• Sosnik A, Seremeta KP. Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv. Colloid Interface Sci. 2015;223:40–54.
   PubMed Web of Science ®Google Scholar
• Paudel A, Worku ZA, Meeus J, et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: Formulation and process considerations. Int J Pharm. 2013;453(1):253–284.
   PubMed Web of Science ®Google Scholar
• Cai YZ, Corke H. Production and properties of spray-dried amaranthus betacyanin pigments. J Food Science. 2000;65(7):1248–1252.
   Web of Science ®Google Scholar
• Srinarong P, de Waard H, Frijlink HW, et al. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. Expert Opin Drug Deliv. 2011;8(9):1121–1140.
   PubMed Web of Science ®Google Scholar
• Miller DA, Gil M. Spray-drying technology. In: R.O. Williams III, A.B. Watts, D.A. Miller, editors. Formul. Poorly water soluble drugs. New York, NY: Springer; 2012. p. 363–442. https://doi.org/https://doi.org/10.1007/978-1-4614-1144-4_10.
   Google Scholar
• Kunz C, Schuldt-Lieb S, Gieseler H. Freeze-drying from organic co-solvent systems, part 2: process modifications to reduce residual solvent levels and improve product quality attributes. J Pharm Sci. 2019;108(1):399–415.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Baek I-H. Fabrication and evaluation of valsartan-polymer- surfactant composite nanoparticles by using the supercritical antisolvent process. Int J Nanomedicine. 2014;9:5167–5176.
   PubMed Web of Science ®Google Scholar
• Meng F, Gala U, Chauhan H. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques. Drug Dev Ind Pharm. 2015;41(9):1401–1415.
   PubMed Web of Science ®Google Scholar
• Mendonsa N, Almutairy B, Kallakunta VR, et al. Manufacturing strategies to develop amorphous solid dispersions: An overview. J. Drug Deliv. Sci. Technol. 2020;55:101459.
   PubMed Web of Science ®Google Scholar
• Gao N, Guo M, Fu Q, et al. Application of hot melt extrusion to enhance the dissolution and oral bioavailability of oleanolic acid. Asian J Pharm Sci. 2017;12(1):66–72.
   PubMed Web of Science ®Google Scholar
• Liu J, Cao F, Zhang C, et al. Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion. Acta Pharm Sin B. 2013;3(4):263–272.
   Web of Science ®Google Scholar
• Censi R, Gigliobianco MR, Casadidio C, et al. Hot melt extrusion: highlighting physicochemical factors to be investigated while designing and optimizing a hot melt extrusion process. Pharmaceutics. 2018;10(3):89.
   Web of Science ®Google Scholar
• Djuris J, Nikolakakis I, Ibric S, et al. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm. 2013;84(1):228–237.
   PubMed Web of Science ®Google Scholar
• Shin S-C, Kim J. Physicochemical characterization of solid dispersion of furosemide with TPGS. Int J Pharm. 2003;251(1-2):79–84.
   PubMedGoogle Scholar
• DiNunzio JC, Brough C, Miller DA, et al. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions. Eur J Pharm Sci. 2010;40(3):179–187.
   PubMed Web of Science ®Google Scholar
• Ellenberger DJ, Miller DA, Kucera SU, et al. Improved vemurafenib dissolution and pharmacokinetics as an amorphous solid dispersion produced by KinetiSol® processing. AAPS PharmSciTech. 2018;19(5):1957–1970.
   PubMed Web of Science ®Google Scholar
• Keen JM, LaFountaine JS, Hughey JR, et al. Development of itraconazole tablets containing viscous kinetisol solid dispersions: in vitro and in vivo analysis in dogs. AAPS PharmSciTech. 2018;19(5):1998–2008.
   PubMed Web of Science ®Google Scholar
• Descamps M, Willart JF, Dudognon E, et al. Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g). J Pharm Sci. 2007;96(5):1398–1407.
   PubMed Web of Science ®Google Scholar
• Willart JF, Descamps M. Solid state amorphization of pharmaceuticals. Mol Pharm. 2008;5(6):905–920.
   PubMedGoogle Scholar
• Khalil R, Ghorab M, Rahman NAE, et al. Characterization of ternary solid dispersions of nimesulide with Inutec SP1 and β-cyclodextrin and evaluation of anti-inflammatory efficiency in rats. Egypt. Pharm. J. 2013;12:46–56.,
   Google Scholar
• Shah B, Kakumanu VK, Bansal AK. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. J Pharm Sci. 2006;95(8):1641–1665.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Aso Y, Yoshioka S, et al. Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP. Int J Pharm. 2011;407(1-2):111–118.
   PubMedGoogle Scholar
• Hu X-Y, Lou H, Hageman MJ. Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement. Int J Pharm. 2018;552(1-2):154–163.
   PubMedGoogle Scholar
• Pungor E, Horvai G. A practical guide to instrumental analysis. Florida, USA: CRC Press; 1994.
   Google Scholar
• Tian B, Tang X, Taylor LS. Investigating the correlation between miscibility and physical stability of amorphous solid dispersions using fluorescence-based techniques. Mol Pharm. 2016;13(11):3988–4000.
   PubMedGoogle Scholar
• Qian F, Huang J, Zhu Q, et al. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion? Int J Pharm. 2010;395(1-2):232–235.
   PubMedGoogle Scholar
• Lodge TP, Wood ER, Haley JC. Two calorimetric glass transitions do not necessarily indicate immiscibility: The case of PEO/PMMA. J Polym Sci B Polym Phys. 2006;44(4):756–763.
   Web of Science ®Google Scholar
• Gupta P, Thilagavathi R, Chakraborti AK, et al. Role of molecular interaction in stability of celecoxib-PVP amorphous systems . Mol Pharm. 2005;2(5):384–391.
   PubMedGoogle Scholar
• Thomas LC. Modulated DSC Paper #1 Why Modulated DSC?; An Overview and Summary of Advantages and Disadvantages Relative to Traditional DS, 2005. http://scholar.googleusercontent.com/scholar?q=cache:_e-4wtBhQsMJ:scholar.google.com/&hl=en&as_sdt=0,28. (accessed May 18, 2020).
   Google Scholar
• Brown ME, Gallagher PK. Handbook of thermal analysis and calorimetry: Applications to inorganic and miscellaneous materials. Amsterdam, The Netherlands: Elsevier; 2003.
   Google Scholar
• Coleman NJ, Craig DQM. Modulated temperature differential scanning calorimetry: A novel approach to pharmaceutical thermal analysis. Int. J. Pharm. 1996;135(1-2):13–29.
   Google Scholar
• Ma X, Williams RO. Characterization of amorphous solid dispersions: An update. J. Drug Deliv. Sci. Technol. 2019;50:113–124.
   Web of Science ®Google Scholar
• Gokhale MY, Mantri RV. Chapter 4 - API Solid-form screening and selection. In: Y. Qiu, Y. Chen, G.G.Z. Zhang, L. Yu, R.V. Mantri, editors. Dev. Solid Oral Dos. Forms Second Ed., Boston: Academic Press; 2017. p. 85–112. https://doi.org/https://doi.org/10.1016/B978-0-12-802447-8.00004-2.
   Google Scholar
• Fan W, Zhu W, Zhang X, et al. Application of the combination of ball-milling and hot-melt extrusion in the development of an amorphous solid dispersion of a poorly water-soluble drug with high melting point. RSC Adv. 2019;9(39):22263–22273.
   PubMed Web of Science ®Google Scholar
• Rumondor ACF, Ivanisevic I, Bates S, et al. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res. 2009;26(11):2523–2534.
   PubMed Web of Science ®Google Scholar
• Newman A, Engers D, Bates S, et al. Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction. J Pharm Sci. 2008;97(11):4840–4856.
   PubMed Web of Science ®Google Scholar
• Bates S, Zografi G, Engers D, et al. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns. Pharm Res. 2006;23(10):2333–2349.
   PubMed Web of Science ®Google Scholar
• Sindhu R, Binod P, Pandey A. Chapter 17 - microbial poly-3-hydroxybutyrate and related copolymers. In: A. Pandey, R. Höfer, M. Taherzadeh, K.M. Nampoothiri, C. Larroche, editors. Ind. Biorefineries White Biotechnol. Amsterdam: Elsevier; 2015. p. 575–605. https://doi.org/https://doi.org/10.1016/B978-0-444-63453-5.00019-7.
   Google Scholar
• Coates J. Interpretation of infrared spectra, a practical approach. In: Encycl. Anal. Chem. Chichester, UK: American Cancer Society, 2006.
   Google Scholar